Investor Relations

PureTech Health is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. We have created a broad and deep pipeline through our experienced research and development team and our extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through our Founded Entities.

View our corporate deck.

Share Price

For Investor Relations inquiries, please contact PureTech's Investor Relations team at: ir@puretechhealth.com.

Corporate Presentation

View Here

Half Year Report 2023

View Here

Analyst Coverage

Investor Relations

Consolidated Cash

Corporate Presentation

Half Year Report 2023

¹The preliminary selected financial results reported by the Company are unaudited, subject to adjustment, and provided as an approximation in advance of the Company's announcement of complete financial results in April 2024.

Investor Relations

Consolidated Cash

Corporate Presentation

Half Year Report 2023

1The preliminary selected financial results reported by the Company are unaudited, subject to adjustment, and provided as an approximation in advance of the Company's announcement of complete financial results in April 2024.

¹The preliminary selected financial results reported by the Company are unaudited, subject to adjustment, and provided as an approximation in advance of the Company's announcement of complete financial results in April 2024.